| Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks (NCT03954743) | GlaxoSmithKline | 2019-07-19 |
| Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks (NCT02914184) | GlaxoSmithKline | 2016-10-27 |
| Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007 (NCT01563146) | GlaxoSmithKline | 2016-02-01 |
| Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis (NCT01978223) | GlaxoSmithKline | 2014-12-01 |
| Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™ (NCT02153333) | GlaxoSmithKline | 2014-02-01 |
| Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in Belgium (NCT01592838) | GlaxoSmithKline | 2013-12-01 |
| Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination (NCT01915888) | GlaxoSmithKline | 2013-08-01 |
| A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia (NCT01733849) | GlaxoSmithKline | 2012-12-01 |
| Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis (NCT01733862) | GlaxoSmithKline | 2012-11-27 |
| Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination (NCT01682005) | GlaxoSmithKline | 2012-08-01 |
| Special Drug Use Investigation for ROTARIX® (NCT01636739) | GlaxoSmithKline | 2012-07-01 |
| Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™ (NCT01435967) | GlaxoSmithKline | 2011-09-01 |
| Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium (NCT01339221) | GlaxoSmithKline | 2011-03-01 |
| Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth. (NCT01198769) | GlaxoSmithKline | 2010-11-11 |
| Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants (NCT01171963) | GlaxoSmithKline | 2010-08-29 |
| Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants (NCT01107587) | GlaxoSmithKline | 2010-04-13 |
| Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine (NCT01110044) | GlaxoSmithKline | 2010-04-01 |
| Study to Evaluate the Safety of Rotarix™ in Chinese Children (NCT01086436) | GlaxoSmithKline | 2010-03-13 |
| Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants (NCT00969228) | GlaxoSmithKline | 2009-08-25 |
| Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants (NCT00938327) | GlaxoSmithKline | 2009-08-03 |
| Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States (NCT00875641) | GlaxoSmithKline | 2009-04-20 |
| Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants (NCT00779779) | GlaxoSmithKline | 2008-11-22 |
| Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants (NCT00750893) | GlaxoSmithKline | 2008-09-02 |
| Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama (NCT00653198) | GlaxoSmithKline | 2008-03-19 |
| Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children (NCT01177826) | GlaxoSmithKline | 2008-02-23 |
| Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania (NCT01253967) | GlaxoSmithKline | 2008-02-01 |
| Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden (NCT00489567) | GlaxoSmithKline | 2007-10-01 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age (NCT00533507) | GlaxoSmithKline | 2007-09-18 |
| Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants (NCT00480324) | GlaxoSmithKline | 2007-06-19 |
| A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants. (NCT00432380) | GlaxoSmithKline | 2007-03-09 |
| Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine. (NCT00420316) | GlaxoSmithKline | 2007-02-12 |
| To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants (NCT00420745) | GlaxoSmithKline | 2007-01-25 |
| A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family. (NCT00396630) | GlaxoSmithKline | 2007-01-23 |
| Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210) (NCT00329745) | GlaxoSmithKline | 2007-01-01 |
| A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine). (NCT00382772) | GlaxoSmithKline | 2006-11-01 |
| Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines (NCT00370318) | GlaxoSmithKline | 2006-09-01 |
| To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam) (NCT00345956) | GlaxoSmithKline | 2006-09-01 |
| To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants) (NCT00363545) | GlaxoSmithKline | 2006-09-01 |
| Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA (NCT00334607) | GlaxoSmithKline | 2006-06-01 |
| Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India (NCT00289172) | GlaxoSmithKline | 2006-02-10 |
| Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants (NCT00241644) | GlaxoSmithKline | 2005-10-01 |
| Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis (NCT00137930) | GlaxoSmithKline | 2005-08-01 |
| Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis (NCT00134732) | GlaxoSmithKline | 2005-07-01 |
| A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh (NCT00139334) | GlaxoSmithKline | 2005-06-01 |
| A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa (NCT00263666) | GlaxoSmithKline | 2005-03-16 |
| To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines (NCT00140686) | GlaxoSmithKline | 2004-09-01 |
| A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants (NCT00197210) | GlaxoSmithKline | 2003-12-01 |
| Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants (NCT00139347) | GlaxoSmithKline | 2003-12-01 |
| Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa (NCT00383903) | GlaxoSmithKline | 2003-09-01 |
| A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants. (NCT00140673) | GlaxoSmithKline | 2003-08-05 |
| Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine (NCT00757770) | GlaxoSmithKline | 2003-08-01 |
| Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months (NCT00385320) | GlaxoSmithKline | 2001-05-31 |
| Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants. (NCT00729001) | GlaxoSmithKline | 2000-11-01 |
| Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants (NCT00425737) | GlaxoSmithKline | 2000-08-01 |